Drug treatment for cancer of the corpus uteri: Protracted stagnation or breakthrough expectation
The paper considers the specific features of the course and therapy of cancer of the corpus uteri on the basis of some clinical and biological characteristics of the tumor. The objective of ongoing and future clinical trials is to expand the arsenal of active drugs and to individualize therapy in pa...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-08-01
|
| Series: | Опухоли женской репродуктивной системы |
| Subjects: | |
| Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/183 |
| _version_ | 1797876092955000832 |
|---|---|
| author | E. V. Artamonova |
| author_facet | E. V. Artamonova |
| author_sort | E. V. Artamonova |
| collection | DOAJ |
| description | The paper considers the specific features of the course and therapy of cancer of the corpus uteri on the basis of some clinical and biological characteristics of the tumor. The objective of ongoing and future clinical trials is to expand the arsenal of active drugs and to individualize therapy in patients with endometrial cancer. |
| first_indexed | 2024-04-10T01:57:51Z |
| format | Article |
| id | doaj.art-ab2a70aeb98e4f99a4b35a758db15208 |
| institution | Directory Open Access Journal |
| issn | 1994-4098 1999-8627 |
| language | Russian |
| last_indexed | 2024-04-10T01:57:51Z |
| publishDate | 2014-08-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Опухоли женской репродуктивной системы |
| spelling | doaj.art-ab2a70aeb98e4f99a4b35a758db152082023-03-13T08:44:33ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272014-08-0103838710.17650/1994-4098-2011-0-3-83-87199Drug treatment for cancer of the corpus uteri: Protracted stagnation or breakthrough expectationE. V. Artamonova0Рассматриваются особенности течения и терапии рака тела матки на основании некоторых клинико-биологических характеристик опухоли. Цель проводимых и будущих клинических исследований — расширение арсенала активных лекарственных агентов и индивидуализация терапии больных раком эндометрия.The paper considers the specific features of the course and therapy of cancer of the corpus uteri on the basis of some clinical and biological characteristics of the tumor. The objective of ongoing and future clinical trials is to expand the arsenal of active drugs and to individualize therapy in patients with endometrial cancer.https://ojrs.abvpress.ru/ojrs/article/view/183рак эндометриямолекулярно-генетические маркерылечение |
| spellingShingle | E. V. Artamonova Drug treatment for cancer of the corpus uteri: Protracted stagnation or breakthrough expectation Опухоли женской репродуктивной системы рак эндометрия молекулярно-генетические маркеры лечение |
| title | Drug treatment for cancer of the corpus uteri: Protracted stagnation or breakthrough expectation |
| title_full | Drug treatment for cancer of the corpus uteri: Protracted stagnation or breakthrough expectation |
| title_fullStr | Drug treatment for cancer of the corpus uteri: Protracted stagnation or breakthrough expectation |
| title_full_unstemmed | Drug treatment for cancer of the corpus uteri: Protracted stagnation or breakthrough expectation |
| title_short | Drug treatment for cancer of the corpus uteri: Protracted stagnation or breakthrough expectation |
| title_sort | drug treatment for cancer of the corpus uteri protracted stagnation or breakthrough expectation |
| topic | рак эндометрия молекулярно-генетические маркеры лечение |
| url | https://ojrs.abvpress.ru/ojrs/article/view/183 |
| work_keys_str_mv | AT evartamonova drugtreatmentforcancerofthecorpusuteriprotractedstagnationorbreakthroughexpectation |